Trial Profile
Effect of Atomoxetine and a standardized behavior therapy on attention deficits in adult ADHD.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jun 2011
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 14 Jun 2011 New trial record